S&T Bank’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.74M | Sell |
68,087
-25,185
| -27% | -$942K | 1.02% | 29 |
|
|
2025
Q4 | $3.25M | Sell |
93,272
-18,068
| -16% | -$1.42M | 1.03% | 34 |
|
|
2025
Q3 | $9.25M | Sell |
111,340
-13,768
| -11% | -$996K | 2.6% | 8 |
|
|
2025
Q2 | $9.18M | Sell |
125,108
-19,187
| -13% | -$1.39M | 2.79% | 3 |
|
|
2025
Q1 | $16.5M | Sell |
144,295
-12,390
| -8% | -$754K | 5.39% | 1 |
|
|
2024
Q4 | $7.9M | Sell |
156,685
-29,331
| -16% | -$1.54M | 2.52% | 7 |
|
|
2024
Q3 | $8.61M | Sell |
186,016
-13,775
| -7% | -$489K | 2.26% | 8 |
|
|
2024
Q2 | $6.49M | Sell |
199,791
-90,696
| -31% | -$2.48M | 1.65% | 23 |
|
|
2024
Q1 | $7.32M | Sell |
290,487
-30,349
| -9% | -$717K | 1.4% | 35 |
|
|
2023
Q4 | $10.4M | Sell |
320,836
-13,416
| -4% | -$368K | 1.93% | 15 |
|
|
2023
Q3 | $9.11M | Sell |
334,252
-13,008
| -4% | -$376K | 1.76% | 26 |
|
|
2023
Q2 | $7.73M | Sell |
347,260
-3,664
| -1% | -$84.3K | 1.39% | 37 |
|
|
2023
Q1 | $7.6M | Buy |
350,924
+4,618
| +1% | +$101K | 1.37% | 38 |
|
|
2022
Q4 | $7.03M | Sell |
346,306
-3,150
| -0.9% | -$79K | 1.3% | 35 |
|
|
2022
Q3 | $8.96M | Sell |
349,456
-149,083
| -30% | -$3.99M | 1.73% | 20 |
|
|
2022
Q2 | $11.9M | Sell |
498,539
-10,007
| -2% | -$218K | 2.08% | 10 |
|
|
2022
Q1 | $11.5M | Sell |
508,546
-5,281
| -1% | -$112K | 1.73% | 22 |
|
|
2021
Q4 | $10.2M | Buy |
513,827
+28,451
| +6% | +$577K | 1.49% | 26 |
|
|
2021
Q3 | $9.55M | Sell |
485,376
-8,038
| -2% | -$168K | 1.48% | 28 |
|
|
2021
Q2 | $10.9M | Sell |
493,414
-4,111
| -0.8% | -$91.5K | 1.69% | 21 |
|
|
2021
Q1 | $11.8M | Sell |
497,525
-45,152
| -8% | -$1.21M | 1.93% | 13 |
|
|
2020
Q4 | $14.2M | Sell |
542,677
-32,600
| -6% | -$687K | 2.55% | 3 |
|
|
2020
Q3 | $10M | Buy |
575,277
+13,965
| +2% | +$223K | 2.29% | 8 |
|
|
2020
Q2 | $9.44M | Sell |
561,312
-27,308
| -5% | -$384K | 2.15% | 10 |
|
|
2020
Q1 | $7M | Sell |
588,620
-16,947
| -3% | -$210K | 1.93% | 17 |
|
|
2019
Q4 | $7.33M | Sell |
605,567
-19,511
| -3% | -$272K | 1.5% | 29 |
|
|
2019
Q3 | $8.86M | Sell |
625,078
-4,748
| -0.8% | -$58.3K | 1.92% | 19 |
|
|
2019
Q2 | $7.02M | Buy |
629,826
+16,086
| +3% | +$179K | 1.54% | 28 |
|
|
2019
Q1 | $7.21M | Sell |
613,740
-13,988
| -2% | -$174K | 1.62% | 27 |
|
|
2018
Q4 | $8.39M | Sell |
627,728
-88,295
| -12% | -$1.17M | 1.95% | 14 |
|
|
2018
Q3 | $10M | Buy |
716,023
+318,254
| +80% | +$4.45M | 1.87% | 18 |
|
|
2018
Q2 | $6.25M | Sell |
397,769
-28,488
| -7% | -$496K | 1.18% | 45 |
|
|
2018
Q1 | $7.01M | Buy |
+426,257
| New | +$7.9M | 1.25% | 40 |
|
Other funds holding CORT
ISL
VPM
VCM
PA
S&T Bank's CORT Position: Q1 2026 in Review
S&T Bank reduced its Corcept Therapeutics (CORT) stake by 27% in Q1 2026, selling an estimated $942K and leaving 68,087 shares worth $2.74M. The position accounts for 1.02% of the portfolio, ranked #29.
S&T Bank first reported a position in CORT in Q1 2018 and has held it in 33 quarters since. The position peaked at $16.5M in Q1 2025. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.
- S&T Bank held 68,087 shares of Corcept Therapeutics worth $2.74M as of Q1 2026.
- S&T Bank sold 25,185 Corcept Therapeutics shares in Q1 2026, an estimated $942K.
- Corcept Therapeutics made up 1.02% of S&T Bank's portfolio in Q1 2026, its #29 holding.
- S&T Bank first reported a position in Corcept Therapeutics in Q1 2018 and has held it in 33 quarters since.
- S&T Bank's Corcept Therapeutics position peaked at $16.5M in Q1 2025.
- 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.
Based on S&T Bank's 13F filing for Q1 2026, filed 13 May 2026.